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Over 20 years ago, the danger/injury model was formulated, claiming that cell stress/tissue injury induces immunity rather 
than the presence of that which is ‘non-self ’. The model 
emerged from two sources. First, its original discovery 
was based on a clinical trial in transplant patients 
which provided compelling evidence that tissue injury 
(allograft injury) induces immunity in the form of 
alloimmunity-mediated allograft rejection.1 Second, 
Matzinger described a self-coherent argument on 
theoretical grounds which concluded stringently that 
the self/non-self discrimination theory of immune 
responses was inappropriate.2 After the (re)discovery 
of innate immunity, the danger/injury theory was 
modified by both groups several times.3–8 It has now 
been proposed that endogenous molecules released 
from stressed or dying cells—termed damage- or 
danger-associated molecular patterns (DAMPs), in 
analogy to the term pathogen-associated molecular 
patterns (PAMPs)—are recognised by pattern 
recognition receptors (PRRs) expressed on/in innate 
immune system cells to promote inflammatory 
pathways. Further, it was stressed that the sensing 
of DAMPs by PRR-bearing dendritic cells (DCs) 
promotes their maturation/activation which is 
associated with the acquisition of immunostimulatory 
capacities to elicit an adaptive immune response.3–8 
Land reported that DAMPs, “such as heat shock 
proteins (HSPs), arising in the stressed allograft, serve 
as endogenous ligands for and interact with Toll-
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abstract: There is increasing interest by physicians in the impact of the innate immune system on human 
diseases. In particular, the role of the molecules that initiate and amplify innate immune pathways, namely 
damage-associated molecular patterns (DAMPs), is of interest as these molecules are involved in the pathogenesis 
of many human disorders. The first part of this review identifies five classes of cell stress/tissue injury-induced 
DAMPs that are sensed by various recognition receptor-bearing cells of the innate immune system, thereby 
mounting inflammation, promoting apoptosis and shaping adaptive immune responses. The DAMPs activate and 
orchestrate several innate immune machineries, including inflammasomes and the unfolded protein response that 
synergistically operates to induce inflammatory, metabolic and adaptive immune pathologies. Two examples of 
autoimmune diseases are discussed as they represent a typical paradigm of the intimate interplay between innate 
and adaptive immune responses.
Keywords: Soft Tissue Injury; Innate Immunity; Inflammation; Receptors, Pattern Recognition; Autoimmunity. 
امللخ�ص: هناك اهتمام متزايد من قبل االأطباء يف اأثر نظام املناعة الفطري عىل مر�س اإلن�ضان. و تلعب اجلزيئات امل�ضخمة مل�ضارات 
املناعة الفطرية، وبخا�ضة اأمناط ال�رضر اجلزيئية املرتابطة )DAMPs(، دورا مهام يف الت�ضبب يف العديد من اال�ضطرابات للإن�ضان.
يحدد اجلزء االأول من هذا اال�ضتعرا�س خم�س فئات من �ضور اإجهاد اخلليا/اإ�ضابات االأن�ضجة الناجم عن DAMPs، التي ي�ضعر بها اجل�ضم 
االلتهاب، وتعزيز موت اخلليا املربمج  إىل ت�ضاعد  توؤدي  الفطري، والتي  التابعة لنظام املناعة  للم�ضتقبلت  بوا�ضطة اخلليا احلاملة 
وت�ضكيل اال�ضتجابات املناعية التكيفية. تفعل ال DAMPs عدة اآليات للمناعة الفطرية ب�ضورة من�ضجمة، مبا يف ذلك  االأج�ضام االلتهابية 
اأمرا�س املناعة  التكيفية. ونناق�س مثالني من  إلحداث االأمرا�س املناعية االلتهابية  التي تعمل بالتاآزر  وا�ضتجابة الربوتني املفتوحة 
الذاتية حيث إنها متثل منوذجا للتفاعل احلميم بني اال�ضتجابات املناعية الفطرية والتكيفية.
مفتاح الكلمات: اإ�ضابات االأن�ضجة الرخوة؛ املناعة الفطرية؛ التهاب؛ امل�ضتقبلت، التعرف على االأمناط؛ املناعة الذاتية.
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like receptors (TLRs) on cells of the innate immune 
system such as donor- or recipient-derived DCs and 
donor-derived vascular cells and, by this engagement, 
activate them”.7 
Today, DAMPs have gained worldwide acceptance 
and these molecules are involved in the pathogenesis 
of many human diseases. In fact, the modern 
interpretation of the danger/injury model suggests that 
most human disorders stem from disturbed/perturbed 
physiological homeostasis as reflected by tissue injury, 
cell stress or even a slight metabolic disruption of 
the extra/intracellular microenvironment. Human 
diseases are now seen to unfold in light of injury-
induced innate immune events. The principal sequelae 
of pathological events are: microbial/non-microbial 
(sterile) stressful stimuli/inciting insults > cell stress/
tissue injury > elicitation of DAMPs > recognition by 
PRR-bearing innate immune cells > activation of the 
innate immune system > infective/sterile inflammatory 
response. Eventually, in the presence of microbial, 
altered-self antigens or tumour antigens, there is an 
adaptive immune response. 
However, it is important to emphasise that a 
complete overview of all clinical disease entities or 
murine disease models is not provided here. Rather, 
the intent of this review is to highlight a few clinical 
diseases considered to be prototypical of the above-
mentioned aetiopathogenic sequelae. With this in 
mind, this review is divided into two. Part I serves 
as a brief introduction to the function of DAMPs in 
autoimmune diseases, particularly systemic lupus 
erythematosus (SLE) and rheumatoid arthritis (RA). 
Part II, to be published at a later date, will investigate 
their relationship with atherosclerosis, metabolic and 
neurodegenerative disorders, cancer and infection. In 
this article, a few relevant aspects of DAMPs-induced 
innate immune mechanisms and responses will be 
described and discussion limited to those DAMPs that 
are currently known to play a major role in human 
diseases. More comprehensive reviews on the biology 
of DAMPs have been published previously.9,10
Damage-Associated 
Molecular Patterns Promote 
Inflammation and Adaptive 
Immunity
The innate immune system is a highly sensitive organ of 
perception; it consists not only of mobile immune cells 
responsible for evoking inflammatory and adaptive 
immune responses (e.g. neutrophils, macrophages 
and DCs), but also of somatic cells responsible for 
mounting fibrogenesis/fibrosis (including epithelial 
cells, fibroblasts and smooth muscle cells). All of these 
different cells are equipped with PRRs to sense cell 
stress and tissue injury. The major response to inciting 
insults is inflammation, with the aim of providing 
protection to the host.11 This includes killing invading 
pathogens, removing damaged/dead cells, repairing 
destroyed tissue via wound healing, balancing 
metabolic or psychological irregularities and inducing 
a supportive adaptive immune response when foreign 
antigens (e.g. altered self-, tumour or microbial 
antigens) are involved. It is important to note that 
inflammatory responses to infection and sterile tissue 
injuries have different purposes. The former aims to 
protect the host from infection and can be coupled 
with the induction of adaptive immunity, whereas the 
latter primarily serves to promote tissue repair.11 
However, although initially beneficial, innate 
immunity-mediated, protective inflammatory 
repair processes can become pathogenic. This may 
occur when there is a low-grade immune response 
which is not efficient enough to eliminate the 
inflammatory trigger, resulting in inappropriate insult 
resolution associated with chronic inflammation. 
Additionally, this can also occur when the response 
is exaggerated and uncontrolled—mostly associated 
with an overproduction of DAMPs—resulting in acute 
systemic hyperinflammatory disorders associated 
with ‘collateral damage’ or chronic overshooting 
repair processes accompanied by fibrosis. In both of 
these scenarios, DAMPs are significantly involved by 
representing the pathological trigger of subsequent 
pathogenetic pathways—but what is the nature of 
these molecules and how do they function?
function and classes of 
damage-associated molecular 
patterns
DAMPs are intracellularly sequestered molecules 
that remain unrecognised by the immune system 
under normal physiological conditions. However, 
under conditions of cellular stress or tissue injury, 
these molecules are either actively secreted by 
stressed immune cells (e.g. exposed on stressed 
cells in terms of neo-antigens) or passively released 
into the extracellular environment from dying cells 
or the damaged extracellular matrix.10,12–14 Of note, 
homeostatic danger signals have recently been 
reported as an emerging class of DAMPs;12 here 
denoted as dyshomeostasis-associated molecular 
patterns, defining an altered pattern of molecules 
reflecting perturbations in the steady-state of the 
intra- and/or extracellular microenvironment which, 
for example, is observed in endoplasmic reticulum 
(ER) stress. In the literature, various definitions and 
interpretations of DAMPs can be found. Therefore, 
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in the current article, DAMPs are didactically divided 
into five classes, with a particular focus on classes I, II 
and V [Table 1]. 
The various classes of sterile inflammation-
promoting DAMPs, like infectious inflammation-
evoking PAMPs, are sensed by a variety of distinct 
PRRs, promoting an inflammatory response. Many 
PRRs and their triggered signalling pathways have 
been comprehensively reviewed.15–22 Figure 1 shows 
some selected DAMPs which are recognised by 
their cognate PRRs to trigger signalling pathways. 
TLR2 senses HSPs, hyaluronan and high-mobility 
group box 1 (HMGB1) with the subsequent myeloid 
differentiation primary response 88 (MyD88)-
dependent pathway that turn on IκB kinase complex 
(IKKs) and mitogen-activated protein kinases 
(MAPKs), leading to the activation of nuclear factor 
kappa B (NF-κB) and activator protein-1 to induce 
inflammatory cytokines. TLR4 senses HSPs and 
HMGB1 with subsequent MyD88- and Toll/interleukin 
(IL)-1 receptor-domain-containing adapter-inducing 
interferon-β (TRIF)-dependent pathways that turn on 
IKKs, MAPKs and serine/threonine-protein kinase-
binding kinase 1 (TBK1), leading to the activation of 
NF-κB and interferon regulatory factor 3 (IRF3) to 
induce type I interferons (IFNs) and cytokines. TLR3 
senses double-stranded ribonucleic acid (RNA) with 
subsequent TRIF-dependent pathways that turn on 
TBK1, leading to the activation of IRF3 to induce 
type I IFNs. TLR7/8 (TLR8 only in humans), sensing 
single-stranded RNA, and TLR9, sensing DNA, use 
the adaptor molecule MyD88 for further signalling. 
In plasmacytoid DCs (pDCs), TLR7/8 and use the 
MyD88-dependent pathway leading to the activation 
of IRF5 and NF-κB to induce inflammatory cytokines 
and IRF7 to induce type I IFNs. Retinoic acid-inducible 
gene-I senses RNA with a subsequent mitochondrial 
antiviral signalling-dependent pathway that turns 
on IKKs and TBK1, leading to the activation of NF-
κB and IRF3 to induce type I IFNs and cytokines. 
Cyclic guanosine monophosphate-adenosine mono-
phosphate (cGAMP) synthase (cGAS) and interferon 
gamma-inducible protein 16 sense DNA with the 
subsequent stimulator of interferon genes (STING)-
dependent pathway that turns on TBK1, leading 
to the activation of IRF3 to induce type I IFNs 
[Figure 1].15,16,19–21
In particular, the recent discovery of the cGAS-
cGAMP-STING pathway has led to the recognition 
that a loss of negative regulation of cytosolic DNA 
sensing will result in the aberrant recognition of 
self-DNA, which is strongly associated with the 
pathogenesis of autoimmune diseases such as lupus.20 
Wu et al. suggest that an increasing understanding 
of cytosolic nucleic acid sensing and of self/altered 
or self/non-self-discrimination mechanisms at the 
molecular level will help in clarifying the pathogenesis 
of autoimmune diseases.20
Table 1: Classification of selected injury-induced 
damage-associated molecular patterns7–10,12–14





DAMPs recognised by 
binding to a receptor, 
including HMGB1, HSPs, 
fHA and nucleic acids 
(e.g. mtDNA and cytosolic 
RNA).
 
TLRs, RAGE, RIG-I, 
MDA5, cGAS, IFI16, on 
macrophages, DCs and 
many somatic cells (e.g. 
fibroblasts).
II* 
DAMPs sensed without 
direct binding to a pattern 
recognition receptor, 
including eATP, MSU, 
TXNIP, ROS and others.
 
NLRP3 inflammasome, 
in macrophages, DCs and 
other somatic cells (e.g. islet 
cells).
III 
MICA, MICB and ULBPs.
 
Activating receptor 
NKG2D, expressed on 
innate lymphocytes (e.g. 
NK cells) and innate-like T 








Pre-existing natural IgM 
antibodies able to activate 
the complement cascade 




molecular patterns, such 
as ER stress-inducing 
molecules (due to 
accumulating unfolded/
misfolded proteins, changes 
in acidity and osmolarity, 
hypoxia, oxidised proteins, 
etc.).
 
Signalling sensors of the 
unfolded protein response 
(PERK, IRE1α → XBP1, 
ATF6).
DAMPs = damage-associated molecular patterns; TLRs = Toll-like 
receptors; RAGE = receptor for advanced glycation end-products; RIG-I 
= retinoic acid inducible gene-I; MDA5 = melanoma differentiation-
associated gene 5; cGAS = cyclic guanosine monophosphate-adenosine 
monophosphate synthase; IFI16 = interferon gamma-inducible protein 
16; HMGB1 = high-mobility group box 1; HSPs = heat shock proteins; 
DCs = dendritic cells; fHA = fragment of hyaluronan; mtDNA = 
mitochondrial DNA; RNA = ribonucleic acid; NLRP3 = nucleotide-
binding oligomerisation domain-like receptor-containing pyrin domain 
3; eATP = extracellular adenosine triphosphate; MSU = monosodium 
urate; TXNIP = thioredoxin-interacting protein; ROS = reactive 
oxygen species; MICA = major histocompatibility complex (MHC) 
class I chain-related protein A; MICB = MHC class I chain-related 
protein B; ULBPs = UL16 binding proteins; NKG2D = natural killer 
group 2 member D; NK = natural killer; IgM = immunoglobulin M; 
NMHC-IIA = non-muscle myosin heavy chain II-A; MBL = mannose-
binding lectin; PERK = protein kinase-like eukaryotic initiation 
factor 2α kinase; IRE1α = inositol-requiring transmembrane kinase/
endoribonuclease 1α; XBP1 = spliced X-box binding protein 1; ER = 
endoplasmic reticulum; ATF6 = activating transcription factor 6.
*Classifications designed for didactic purposes only as some DAMPs 
reportedly show overlapping functions.
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damage-associated molecular 
patterns evoke inflammation 
and apoptosis
Innate immune cells constitute the first line of defence 
and are involved in recognising an initial threat, 
containing infectious/sterile insults and promoting 
the recruitment of additional immune cells through 
the release of cytokines and chemokines. Thus, 
inflammation serves as a tissue protective mechanism 
in mammals. On the other hand, apoptosis (a form of 
programmed cell death) can be regarded as a species-
wide evolutionary-conserved cellular protective 
mechanism. Both protective mechanisms are 
promoted by DAMPs via inflammasome-independent 
and -dependent innate immune pathways. Of note, the 
IL-1 family of cytokines (IL-1α and -1β) plays a key role 
in infectious/sterile inflammatory diseases.23–25 Both 
IL-1α and -1β provoke potent pro-inflammatory events 
by engaging the IL-1 receptor. Following tissue damage 
and necrosis, biologically active IL-1α can be released, 
serving as the primary initiating signal to coordinate 
mobilisation of immune cells to the damaged area.23,24 
IL-1α signalling results in dramatic production of 
cytokines and chemokines that function to orchestrate 
the expansion and recruitment of phagocytes to the 
site of damage. IL-1β also plays a crucial pathogenic 
role in multiple major inflammatory and autoimmune 
diseases.23,24 However, while IL-1α is constitutively 
expressed in both immune and parenchymal cells, 
thus not requiring biological processing, IL-1β is 
not expressed at appreciable levels by circulating 
cells and therefore has to be processed.23,24 The most 
well-characterised mechanism for processing IL-1β 
is via activated caspase-1 in the canonical inflam- 
masome complex. 
Canonical inflammasomes are multiprotein 
complexes that generally consist of three main 
components: a cytosolic sensor molecule, the 
enzyme caspase-1 and the adaptor protein apoptosis-
associated speck-like protein containing caspase-
recruit-ment domain (ASC). Members of the nucleo-
tide-binding oligomerisation domain-like receptor 
(NLR) and AIM2-like receptor (ALR) families are 
established cytosolic sensor molecules that mediate 
inflammasome formation.22,26–28 Certainly, DAMPS-
activated inflammasomes play a pivotal role in 
promoting innate immune pathways to mount 
inflammation and shape adaptive immune responses. 
In particular, the NLR-containing pyrin domain 
3 (NLRP3) inflammasome—the most studied 
Figure 1: Simplified model illustrating DAMPs and their cognate PRRs triggering selected signalling pathways involved 
in mounting inflammatory responses. The PRRs are located in TLR2 and 4, RAGE (cell membrane-bound), TLR3, 7/8 
and 9 (endosomal membrane-bound), cGAS, IFI16 and RIG-I (cytosolic).
DAMPs = damage-associated molecular patterns; PRRs = pattern recognition receptors; TLR = Toll-like receptor; RAGE = receptor for advanced 
glycation end-products; cGAS = cyclic guanosine monophosphate-adenosine monophosphate synthase; IFI16 = interferon gamma-inducible 
protein 16; RIG-I = retinoic acid inducible gene-I; HSPs = heat shock proteins; HA = hyaluronan; HMGB1 = high-mobility group box 1; ssRNA 
= single-stranded ribonucleic acid; dsRNA = double-stranded RNA; MyD88 = myeloid differentiation primary response 88; TRIF = Toll/
interleukin-1 receptor-domain-containing adapter-inducing interferon-β; MAVS = mitochondrial antiviral signalling; RAS = ras protein; Mito = 
mitochondria; IKKs = IκB kinase complex; MAPKs = mitogen-activated protein kinases; TBK1 = serine/threonine-protein kinase-binding kinase 
1; STING = stimulator of interferon genes; ER = endoplasmic reticulum; NF-κB = nuclear factor kappa B; AP-1 = activator protein-1; IRF3 = 
interferon regulatory factor 3; IFNs = interferons. 
Green = adaptor molecules. Blue = distal kinases. Pink = transcription factors.
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inflammasome to date—operates as a key signalling 
platform contributing non-exclusively to DAMPs-
induced sterile inflammatory/adaptive immune T 
cell responses. This occurs via the production of 
key cytokines IL-1β and -18, but may also instigate 
proapoptotic/pyroptotic pathways.27,29 Pyroptosis is 
a rapid inflammatory form of cell death that shares 
characteristics with both apoptosis (such as DNA 
fragmentation) and necrosis (such as cell swelling 
and rupture). 
Apart from extracellular pathogen-derived 
PAMPs, many DAMPs elicited by various types 
of cellular stress/tissue injury trigger activation of 
the NLRP3 inflammasome. In these instances, the 
activation status is modulated to avoid aberrant 
activation. In particular, there is evidence suggesting 
a two-step activation process: an initial priming 
step and a secondary activating step that activates 
the NLRP3 inflammasome assembly.22,27–30 Thus, in 
macrophages, recruitment of NLRP3 and upregulation 
of pro-IL-1β/-18 protein levels are controlled by 
the transcriptional priming step triggered by class I 
DAMPs that stimulate PRRs such as TLRs upstream 
of the transcription factor NF-κB. Subsequently, class 
II DAMPs, including cholesterol, uric acid crystals 
and amyloid-β derived from lysosomal leakage 
and mediated via ion fluxes (potassium efflux and 
calcium [Ca] influx) activate the NLRP3 inflam- 
masome assembly.
Therefore, priming (through class I DAMPs 
such as HMGB1, HSPs or oxidised low-density 
lipoproteins) via TLR sensing induces transcription-
mediated and mitochondrial reactive oxygen species 
(ROS)-promoted upregulation of the NLRP3 receptor 
and production of pro-IL-1β. Finite activation of the 
inflammasome is provided by class II DAMPs (such as 
thioredoxin-interacting protein [TXNIP], extracellular 
adenosine triphosphate [eATP], cholesterol, islet 
amyloid polypeptide [IAPP] and amyloid β) which 
are directly or indirectly sensed by NLRP3 via various 
mechanisms. However, there is scarce evidence that 
NLRP3 binds directly to all of the different class 
II DAMPs. In fact, NLRP3 is believed to act as a 
sensor rather than a true receptor and its activation 
is thought to be triggered by signalling intermediates. 
Moreover, the events leading to NLRP3 activation 
appear to involve pathways mediating mitochondrial 
damage and the release of mitochondrial content into 
the cytosol, such as oxidised mitochondrial DNA. In 
addition, high levels of eATP activate NLRP3 after 
eATP binds to the P2X purinoceptor 7. Moreover, 
ROS production has a pivotal role in NLRP3 activation. 
In fact, ROS may exert its activating effect indirectly or 
directly by leading to the dissociation of TXNIP from 
thioredoxin, freeing the protein to interact with and 
activate NLRP3. Although the exact mechanisms are 
still unclear, activation of NLRP3 allows inflammasome 
complex formation and maturation of pro-IL-1β and 
Figure 2: Simplified model illustrating the DAMPs-induced activation of the NLRP3 inflammasome.
DAMPs = damage-associated molecular patterns; NLRP3 = nucleotide-binding oligomerisation domain-like receptor-containing pyrin domain 
3; HMGB1 = high-mobility group box 1; HSPs = heat shock proteins; oxLDL = oxidised low-density lipoproteins; eATP = extracellular adenosine 
triphosphate; IAPP = islet amyloid polypeptide; oxDNA = oxidised DNA; TXNIP = thioredoxin-interacting protein; P2X7R = P2X purinoceptor 
7; K+ = potassium ion; TLRs = Toll like receptors; ROS = reactive oxygen species; Pan.-1 = pannexin 1 haemichannel; non-Pan. = non-pannexin 
1 haemichannel; IL-1β = interleukin-1 (IL-1)-beta; NF κB = nuclear factor kappa B; MPKs = mitogen activated protein kinases; IL-1R = IL-1 
receptor.
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18 via caspases 1 cleavage to secretion of bioactive IL-
1β and -18 after caspase-1-dependent proteolysis from 
their pro-forms. These key cytokines, in an autocrine 
or paracrine manner, then lead to IL-1 receptor-
triggered transcriptional pathways resulting in the 
production of further pro-inflammatory mediator 
substances (such as IL-6, chemokines and adhesion 
molecules) to create full scale tissue inflammation 
[Figure 2].17,26–30
Notably, besides the secretion of these two key 
cytokines, capase-1 activation has been shown to result 
in cell death via pyroptosis. Of note, although numerous 
potential unifying models for NLRP3 activation have 
been presented, no single mechanism proposed thus 
far appears to account for all possible pathways of how 
DAMPs activate NLRP3. In addition, it has become 
increasingly apparent that inflammasome activation 
is not as simple as once thought and additional 
caspases, including caspase-8 and -11, as well as other 
modulators, have been found to play critical roles in 
IL-1β cleavage and secretion.25,27,29,30
A new player has also recently entered the arena 
of innate immunity: the unfolded protein response 
(UPR).31,32 Emerging evidence indicates that the UPR 
may play a significant role in human diseases as an 
essential tool of the innate immune system by allowing 
crosstalk with other molecular machineries of the 
defense system, such as the NLRP3 inflammasome. 
The UPR regulates any ER stress associated with, for 
example, the accumulation of unfolded/misfolded 
proteins.33–36 The ER is a subcellular organelle of the 
eukaryotic cell that is responsible for Ca2+ ion storage 
and lipid biosynthesis as well as the synthesis, correct 
folding, processing, maturation and trafficking of 
proteins via the Golgi apparatus destined to be secreted 
or inserted into the plasma membrane. Perturbations 
of the ER reflect the generation of homeostatic 
danger signals (class V DAMPs) sensed by three UPR 
sensor molecules: the protein kinase-like eukaryotic 
initiation factor 2α kinase (PERK), inositol-requiring 
transmembrane kinase /endoribonuclease 1α (IRE1α) 
and activating transcription factor 6 (ATF6). 
In non-stressed conditions, these three sensors 
of the ER homeostasis are kept in an inactive state 
by the ER luminal protein BiP/GRP78. However, 
in conditions of ER stress (e.g. the depletion of Ca2+ 
ions, increase in Ca2+ concentration, overloading of 
unfolded/misfolded proteins within the ER lumen, 
disturbances in lipid metabolism or changes in the ER 
redox state), BiP is titrated away from these sensors 
in order to carry out its chaperoning functions that 
are crucial for the correction of ER homeostasis. This 
allows the activation of the three sensors and their 
emanating signalling pathways, collectively termed 
as the UPR, strive to restore ER homeostasis. Under 
remediable ER stress conditions, the three sensors 
trigger signalling pathways to resolve ER stress; this is 
the pro-survival facet that is used to maintain cellular 
integrity (adaptive response). This facet includes 
processes like PERK-mediated phosphorylation of 
Figure 3: Simple model illustrating ER stress and the UPR. 
ER = endoplasmic reticulum; UPR = unfolded protein response; DAMPs = damage-associated molecular patterns; PERK = protein kinase-like 
eukaryotic initiation factor 2α kinase; IRE1α = inositol-requiring transmembrane kinase/endoribonuclease 1α; ATF = activating transcription 
factor; eIF2α = eukaryotic translational initiation factor 2α; XBP1 = X-box binding protein 1; ASK1 = apoptosis-signalling kinase 1; JNK = c-JUN 
N-terminal kinase; CHOP = cytidine-cytidine-adenosine-adenosine-thymidine-enhancer-binding homologous protein.
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eukaryotic initiation factor 2 (eIF2) that is required 
in the initiation of translation. This translation 
initiation factor functions by leading to temporary 
attenuation of the protein synthesis, which allows 
the load of incoming naïve proteins to be reduced. 
Further, eIF2 stimulates retention of Ca2+ and prevents 
aggregation of unfolded proteins by IRE1α and ATF6-
mediated transcription of the X-box binding protein 1 
(XBP1). XBP1 is a transcription factor that regulates 
the expression of genes important for the proper 
functioning of the UPR by ensuring the transcription 
of ER chaperones.33–36
However, in cases of severe irremediable ER stress, 
the balance is tipped in favor of pro-death signalling; 
that is, the UPR may lead to pro-inflammatory and 
proapoptotic responses, resulting in catastrophic 
cell death [Figure 3]. This part of the cascade is 
mediated by different processes, like PERK-mediated 
upregulation of the cytidine-cytidine-adenosine-
adenosine-thymidine-enhancer-binding homologous 
protein (CHOP), which induces the downregulation 
of B-cell lymphoma 2 (Bcl-2) and the transcriptional 
activation of ER-oxidase 1α, finally leading to apoptosis. 
Additionally, IRE1α is also known to play a role in ER 
stress-induced apoptosis.31,32,36,37 
In summary, the three sensor molecules (PERK, 
IRE1α and ATF6) serve as tools of the innate immune 
system to combat dangerous cell stress; thus, they 
operate as recognition receptors similar to TLRs 
or NLRs. In their function as sensors, these three 
molecules may be regarded as a new family of PRRs, 
at least in a wider sense, which are able to sense 
homeostatic danger signals in terms of class V DAMPs. 
damage-associated molecular 
patterns shape adaptive 
immunity
The important role of DAMPs in human diseases is 
reflected by their capacity to initiate innate immune 
pathways that not only lead to tissue inflammation 
but also, via activation of specialised antigen-
presenting cells (APCs), shape the adaptive immune 
responses involved in autoimmunity and anti-tumor 
and antimicrobial immunity. Doubtlessly, the key 
event of innate immunity that initiates and induces 
pathways, ultimately resulting in the development of 
an adaptive immune response, is seen in the DAMPs-
induced maturation of steady-state immature DCs 
(iDCs) into immunostimulatory DCs. In short, the 
professional APCs translate innate immunity to 
adaptive immunity, dictating the type and course of 
adaptive immune responses. As reviewed elsewhere, 
this fundamental process of tissue injury-induced 
DC maturation involves large-scale changes in 
the expression of genes encoding a broad array of 
proteins.10,12,37,38 These changes include, but are not 
limited to, the upregulation of expression of major 
histocompatibility complex (MHC) molecules (signal 
1) and costimulatory molecules (signal 2), the secretion 
of type 1 T-helper (Th1) and Th17 polarising cytokines 
such as IL-12 (signal 3), and, lastly, the secretion of 
chemokines such as C-C chemokine receptor type 7 
(CCR7) enabling maturing DCs to migrate to T cell 
areas within the secondary lymphoid organs.10,12,37,38 
Interestingly, during this process, DCs undergo a 
metabolic transition from oxidative phosphorylation 
to aerobic glycolysis. Having developed these 
characteristic properties, the cells then instruct naïve 
T lymphocytes in the host’s secondary lymphoid tissue 
to mount adaptive immune responses. 
All five classes of DAMPs, via different direct and 
indirect mechanisms, have been shown to promote 
the development of those immunostimulatory DCs 
that are able to efficiently present antigens (altered-
self, tumour or microbial antigens), together with 
signal 2 and 3, to naïve T cells, thereby eliciting an 
adaptive immune response [Figure 4].10,12,37,39 Thus, 
class I DAMPs (such as HMGB1 and HSP70) directly 
stimulate PRRs (such as TLRs of DCs) to initiate 
pathways leading to their activation. This may occur 
via recognition by TLR4 (essential for DC activation in 
an anti-tumour T cell response), TLR2 or the receptor 
for advanced glycation end-products (RAGE). Further, 
nucleic acids acting as class I DAMPs, such as double-
stranded DNA (dsDNA), are recognised by TLR9 and 
other DNA sensors (such as cGAS as recently shown 
in murine conventional DCs). These are key events 
in converting iDCs to mature immunostimulatory 
DCs.40,41 In addition, class II DAMPs, via activation 
of the NLRP3 inflammasome in cooperation with 
class I DAMPs, contribute to the shaping of adaptive 
immunity via the creation of an inflammatory milieu 
that is generally regarded as a necessary condition 
for full activation of DCs. As reviewed, one obvious 
link between NLRP3 inflammasome and adaptive 
immunity is the key cytokine IL-1β which enhances 
expansion and survival of T cells, promotes 
differentiation of potentially pathogenic Th17 cells 
and can promote APC migration, thereby potentially 
enhancing antigen presentation.28 Moreover, class III 
DAMPs (such as MHC class I chain-related proteins 
A and B), exposed on stressed cells can assist in DC 
maturation via recognition by the activating receptor 
natural killer group 2 member D on innate lymphocytes 
such as natural killer (NK) cells. Interestingly, the 
bi-directional crosstalk between DCs and NK cells 
during immune responses has been clearly elucidated. 
An intense crosstalk between these two cell types not 
only results in the development of an efficient innate 
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response through DC-mediated NK cell activation, 
but also a potent adaptive immune response through 
NK-mediated DC editing and maturation.42
In addition, class IV DAMPs in terms of injury-
induced neo-antigens/neo-epitopes contribute to 
DC maturation via activation of the complement 
cascade. As shown in a study on reperfusion injury 
models, one possible trigger mechanism leading 
to activation of the complement cascade is the 
binding of autoreactive natural immunoglobulin M 
antibodies to these neo-epitopes.43 As so far detected, 
these oxidation-specific neo-epitopes include 
non-muscle myosin heavy chain IIA (NMHC-II), 
actin cytoskeleton and phosphocholine of oxidised 
phospholipids and malondialdehyde.44–46 In fact, 
injury-induced complement activation may contribute 
to the generation of immunostimulatory DCs mainly 
through the classical, alternative and lectin pathways. 
Via the terminal products, the complement fragments 
C5b-9, known as the complement membrane attack 
complex, via its lytic action, aggravates cell and tissue 
injury, thereby increasing the induction of class I, II 
and III DAMPs and, thus, indirectly contributing to 
DC maturation.47 Via the small fragments C3a and 
C5a, the activated complement cascade contributes 
to the creation of tissue inflammation. Interestingly, in 
studies on murine and human DCs, the complement 
fragment C5a was shown to render iDCs competent 
for inflammatory cytokine production under non-
infectious conditions.48 Moreover, via the small 
fragments C3a and C5a released during the course 
of complement activation, human iDCs have 
recently been demonstrated to undergo phenotypic 
maturation as well as functional modulation.49 These 
observations suggest a more direct action of the 
activated complement cascade on the generation 
of immunostimulatory DCs. Finally, some evidence 
has been reported suggesting that class V DAMPs 
associated with ER stress, under involvement of the 
regulator XBP1, contribute to DC maturation and 
activation induced by HMGB1.37,39
Altogether, these various DAMP-induced 
scenarios are involved in the pathogenesis of many 
human diseases. For this reason they are outlined in 
this two-part review in more detail. Two examples 
of autoimmune diseases will be discussed at first 
since they represent a typical paradigm of the 
intimate interplay between innate and adaptive 
immune responses. 
Autoimmune Diseases
The ability of DAMPs to shape adaptive immunity has 
been impressively documented in human autoimmune 
diseases. In the presence of altered-self antigens, 
DAMPs instigate DC-driven innate immune pathways 
that promote adaptive autoimmune responses which 
manifest as severe clinical symptoms; this may also 
Figure  4: Simplified model depicting the role of five classes of DAMPs in the maturation/activation of immunostimulatory 
DCs to migrate to secondary lymphoid tissue and induce an adaptive T cell immune response. 
DAMPs = damage-associated molecular patterns; DCs = dendritic cells; neoAg = neo-antigens; IgM = immunoglobulin M; NKG2D = natural 
killer group 2 member D; mDC = mature DC; ER = endoplasmic reticulum; NLRP3 = nucleotide-binding oligomerisation domain-like receptor-
containing pyrin domain 3; TLRs = Toll-like receptors; MØ = macrophage; UPR = unfolded protein response; IL-1β = interleukin-1-beta; NK = 
natural killer; MHC = major histocompatibility complex; UCM = upregulated costimulatory molecules; TCR = T cell receptor.
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be compared in Figure 4. These disorders comprise 
numerous and diverse pathologies from organ-
specific disorders, such as multiple sclerosis and type 
1 diabetes, to systemic autoimmune manifestations, 
such as systemic lupus erythematosus (SLE) and RA. 
systemic lupus erythematosus
SLE is a complex autoimmune condition in which 
autoantibodies against nucleic acids (for example, 
dsDNA) and associated proteins in concert with IFNs, 
trigger immune-complex-mediated inflammation that 
results in organ damage. Multifactorial stimuli are 
considered triggers, including environmental insults 
such as smoking, ultraviolet radiation, viral infections, 
hormonal imbalances and drug-mediated insults. 
These promote and precipitate SLE in a genetically 
predisposed individual. Notably, most of those insults 
are mediated by uncontrolled oxidative stress that 
contributes to functional oxidative modifications 
of cellular protein, lipid and DNA; consequently, 
this oxidative modification plays a crucial role in 
immunomodulation and triggering the autoimmune 
process.50,51 
Several lines of experimental and clinical evidence 
support the notion that oxidative stress-related injuries 
are manifested by a disturbed clearance of apoptotic 
cells as a consequence of a defect in the recognition 
and phagocytosis of apoptotic cells, their subsequent 
accumulation being instrumental in the development 
of SLE.51,52 Insufficiently cleared apoptotic debris 
then leads to secondary necrotic changes associated 
with the release of neo-epitopes such as dsDNA. 
Importantly, these autoantigens simultaneously act as 
host DAMPs, mostly in the form of immune-protein 
complexes such as HMGB1, cytosolic self-dsDNA 
and self-RNA. It has been suggested that the excessive 
release of intact nucleosomes could be the source of 
those DAMPs.52–56
Numerous studies, including experiments on cell 
lines and in mouse knockout systems, have shown 
that various receptors of the TLR, NLR, RLR and ALR 
families are involved in the pathogenesis of SLE, via 
sensing key SLE-eliciting DAMPs (i.e. HMGB1 and 
self-nucleic acids). These studies demonstrate that 
this occurs by the promotion of inflammation and 
DC maturation, which thereby elicit an autoimmune 
response [Figure 5].19–21,55–60 Remarkably, recent 
findings from experiments in mice and in vitro studies 
on human monocytes have provided evidence that 
also suggest a role of the NLRP3 inflammasome in 
the pathogenesis of lupus. It has been particularly 
demonstrated that self-dsDNA together with its 
autoantibodies induces IL-1β production.61–63
Of note, DAMPs involved in SLE (such as cytosolic 
dsDNA in terms of DNA-immune complexes, but also 
RNA and HMGB1), in cooperation with signalling 
pathways leading to NF-κB activation, have been 
shown to generate potent immunostimulatory human 
Figure 5: Simplified model of the role of DAMPs as well as the distinct roles of cDCs and pDCs in SLE. 
DAMPs = damage-associated molecular patterns; DC = dendritic cell; cDC = conventional DC; pDC = plasmacytoid DC; HMGB1 = high-
mobility group box 1; TLR = Toll-like receptor; RAGE = receptor for advanced glycation end-products; RNA = ribonucleic acid; ssRNA = single-
stranded RNA; RIG-I = retinoic acid inducible gene I; IFI16 = interferon gamma-inducible protein 16; AIM2 = absent in melanoma 2 protein; 
MDA5 = melanoma differentiation-associated gene 5; cGAS = cyclic guanosine monophosphate-adenosine monophosphate synthase; dsDNA = 
double-stranded DNA; NF-κB = nuclear factor kappa B; autoAg = auto-antigen. 
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DCs that elicit strong adaptive immune responses.64 
In fact, innate immune events in SLE induced by 
the aforementioned DAMPs are translated by PRR-
bearing DCs into the adaptive autoimmune response 
that is typical for this disease. On one hand, self-nucleic 
acid DAMPs-activated conventional dendritic cells 
(cDCs) not only produce pro-inflammatory cytokines 
and chemokines, but also possess a potent ability 
to present antigens to autoreactive T cells, thereby 
leading, for example, to autoantibody production by 
B cells.64–67 On the other hand, another category of 
DCs, the plasmacytoid DCs, after sensing self-nucleic 
acid DAMPs by TLR7 and 9, promote the production 
of antinuclear autoantibodies and type I IFNs, which 
are both correlated with the severity of SLE. In fact, 
increasing evidence suggests that pDCs are essential 
for the initiation of the abnormal innate immune 
responses that lead to systemic SLE autoimmunity. It 
is likely that this occurs through the promotion of cDC 
maturation and a high production of type I IFNs.66–69 
rheumatoid arthritis
RA is a chronic inflammatory autoimmune disease 
of the synovial joints and the surrounding connective 
tissue. Untreated, the disease can cause cartilage 
destruction, bone erosion and tendon fracture, leading 
to the deformation and dysfunction of joints. In 
addition to disability and a decreased quality of life, 
RA is associated with reduced life expectancy due to 
comorbidities and complications, most commonly 
from accelerated atherosclerosis. Many different cell 
populations in the RA joint secrete cytokines and 
other inflammatory mediators, which contribute to 
pathogenesis. Macrophages are considered a major 
effector of synovitis, secreting cytokines including 
tumour necrosis factor IL-1 and -6. In this disease, 
genetics, epigenetic modifications and environmental 
factors such as infections and smoking interact and 
culminate in the production of specific polyclonal 
autoantibodies including rheumatic factor (directed 
against the Fc region of immunoglobulin G molecules), 
anticitrulline protein antibodies and anti-carbohydrate 
antibodies.70–74 
There is now ample evidence suggesting that, 
in RA patients, complex DAMPs-induced events 
mediated by PRR-bearing innate immune cells are 
involved in joint inflammation and the formation of 
these autoantibodies.75–78 Various TLRs expressed on 
blood monocytes, synovial fibroblasts or macrophages 
from synovial fluid from patients with RA have been 
implicated as potential contributors in the pathogenesis 
of RA, including TLR2 and 4 as well as endosomal 
TLR3, 7 and 9.75–78 Furthermore, a recent study found 
evidence of modulation of the NLRP3-inflammasome 
in patients with RA, pointing to the broad spectrum 
of innate immune machineries operating in the 
pathogenesis of rheumatoid diseases.79
The question remains regarding what types of 
insults elicit DAMPs and potentially promote joint 
inflammation and autoantibody formation in RA. 
There is increasing data supporting the notion that 
both microbe-mediated infectious and sterile tissue 
damage evoke DAMPs that function as contributors 
to the persistence of joint inflammation and the 
progression of joint destruction after recognition by 
TLRs. These include HSP22, 70 and the 90 family 
member, glycoprotein-96, as well as HMGB1 and 
biglycan.77,80‒85 Moreover, RNA released by necrotic 
synovial fluid cells from patients with RA has been 
shown to activate endosome-located TLR3 on cultured 
RA synovial fibroblasts.86 
Outlook
The discovery of the danger/injury model has led to 
modern notions about the human immune system, 
revealing that it does not always attack and destroy 
the non-self per se. In contrast, the immune system 
has a strong interest in preserving the ‘non-self ’ 
provided it is beneficial and does not cause harm.87 
This function, together with the rigorous intention of 
an immune response to choke off and/or repair any 
tissue injury—including even the slightest intra- or 
extracellular perturbation on a molecular level (such 
as an abnormal accumulation of proteins in the ER)—
serves one unique objective: to maintain and restore 
the homeostasis of an organism. However, there is 
another side of the coin, which is that uncontrolled 
exaggerated responses of the immune system can 
lead to inflammatory collateral tissue damage and 
some forms of autoimmunity and autoinflammatory 
diseases. The delicate balance therefore required is the 
result of complex cellular, humoural and biochemical 
interactions. The form, concentration and function 
of the various classes of DAMPs are apparently 
not only involved in maintaining this balance but 
can even promote a catastrophic imbalance leading 
to pathologies. 
Furthermore, another layer of complexity is added 
by the fact that homeostatic danger signals (class 
V DAMPs) are increasingly suspected of playing a 
crucial role in the ER stress-induced UPR. In fact, the 
author of this review article proposes that, as similarly 
discussed in the context of microbial/viral-triggered 
ER stress elsewhere, all ER stress-associated perturbed 
molecular patterns (including sterile) are detected by 
three sensor molecules—PERK, IRE1α and ATF6—
thereby inducing an UPR.88,89 This stress response 
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represents an integral part of innate immunity-
regulated transcription programmes in terms of a 
continuous crosstalk with other DAMPs-induced 
and PRRs-controlled defence machineries, such as 
the NLRP3 inflammasome. In light of the danger/
injury model, innate sensing of any infectious or sterile 
injury appears to always be associated with a UPR 
that, in a hierarchical sense, may either be secondarily 
activated by initial PRR-controlled pathways (e.g. 
TLR-triggered) or may primarily activate other innate 
immune pathways (inflammasome-dependent or 
-independent) to combat dangerous life-threatening 
conditions.88 These pathways in commission of the 
innate immune system are not necessarily exclusive, 
but may cooperate under orchestration of the 
various classes of DAMPs to ultimately promote and 
boost vigorous full-scale inflammatory and immune 
responses needed to maintain and restore homeostasis.
However, as already stressed above, when 
uncontrolled, these pathways may lead to pathologies. 
In fact, the scenario of cell stress/tissue injury-induced 
innate immune pathways in terms of UPR-PRR-
inflammasome synergism, as has been briefly outlined 
above, is pathologically implicated in many human 
diseases, including atherosclerosis, metabolic and 
neurodegenerative disorders, cancer and infection.
Conclusion
This review identified five classes of cell stress/tissue 
injury-induced DAMPs and discussed the relationship 
between innate and adaptive immune responses in SLE 
and RA. The discovery of the crucial role of DAMPs in 
the pathogenesis of human autoimmune diseases has 
recently attracted considerable research interest. The 
interplay between the innate and adaptive immune 
system has stimulated strong interest in developing 
new treatment modalities for autoimmune diseases. 
Either distinct DAMPs of interest or components 
of PRR signalling pathways appear to be highly 
relevant targets for new treatment options for those 
with autoimmune diseases. Of course, concerns will 
always be raised over targeting molecules executing 
vital key functions within the innate immune system 
responsible for the maintenance of homeostasis. 
Solving these concerns will be a critical objective of 
future research work. 
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